top of page
Scientific publications
Since its inception, CIPHE has contributed to more than 150 publications in peer-reviewed journals. The team has also participated in nearly fifty international conferences, presenting their work through oral communications and posters. The seven publications highlighted below illustrate a fraction of CIPHE’s extensive scientific output, and are directly derived from the technological research developed at the center.
bioRxiv
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Demerle C, Gorvel L, Mello M, et al.
2022
EMBO Journal
Single-cell transcriptomics uncovers an instructive T-cell receptor role in adult γδ T-cell lineage commitment
Scaramuzzino S, Potier D, Ordioni R, et al.
2022
EBioMedicine
Design, immunogenicity, and efficacy of a pan-sarbecovirus dendritic-cell targeting vaccine
Coléon S, Wiedemann A, Surénaud M, et al.
2022
J Exp Med
Systems-level conservation of the proximal TCR signaling network of mice and humans
Nicolas P, Ollier J, Mori D, et al.
2022
Immunity
Meningeal macrophages protect against viral neuroinfection
Rebejac J, Eme-Scolan E, Paroutaud L, et al.
2022
Front Immunol
Conditional Deletion of Pdcd1 Identifies the Cell-Intrinsic Action of PD-1 on Functional CD8 T Cell Subsets for Antitumor Efficacy
Raghavan S, Tovbis-Shifrin N, Kochel C, et al.
2021
Lancet
Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing’s syndrome: a multicentre, retrospective, cohort study
Chasseloup F, Bourdeau I, Tabarin A, et al.
2021
Nature Immunology
Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections
Ngo C, Pierini-Malosse C, Rahmani K, Zarubica A, et al.
2025
Cancer Immunology Immunotherapy
High baseline PD-1+ CD8 T Cells and TIGIT+ CD8 T Cells in circulation associated with response to PD-1 blockade in patients with non-small cell lung cancer
Dutta N, Svensson J, Saad GA, Luche H, et al.
2025
Oncoimmunology
Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression
Pervizou D, De Chiara J, Spinelli L, Fiore F, et al.
2025
J Exp Med
A CARMIL2 gain-of-function mutation suffices to trigger most CD28 costimulatory functions in vivo
Zhang F, Celis-Gutierrez J, Zhang L, Fiore F, et al.
2025
Nature Communications
Improving laboratory animal genetic reporting: LAG-R guidelines
Teboul L, Amos-Landgraf J, Benavides FJ, et al.
2024
Science
The immunopathological landscape of human pre-TCRα deficiency: From rare to common variants
Materna M, Delmonte OM, Bosticardo M, Luche H et al.
2024
J Neuroinflammation
Cytomegalovirus infection of the fetal brain: intake of aspirin during pregnancy blunts neurodevelopmental pathogenesis in the offsprin
Tarhini S, Crespo-Quiles C, Buhler E, Luche H, et al.
2024
JHEP Rep
Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome
Robert F, Benchenouf F, Ha MN, Fiore F, et al.
2024
Frontiers in Cellular and Infection Microbiology
A novel mass cytometry protocol optimized for immunophenotyping of low-frequency antigen-specific T cells
Balz K, Grange M, Pegel U, Luche H, et al.
2024
J Immunotherapy Cancer
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors
Demerlé C, Gorvel L, Mello M, Zarubica A, et al.
2023
Mamm Genome
INFRAFRONTIER quality principles in systemic phenotyping
Ehlich H, Cater HL, Flenniken AM, Zarubica A, et al.
2022
European Journal of Immunology
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza A, Chang HD, Radbruch A, et al.
2022
bottom of page